SPONSOR CONSIDERATIONS FOR EAPs

If your company is developing a drug that fulfils an unmet clinical need, you may have already started receiving patient enquiries about expanded access.

We have put together this downloadable resource that lists the kinds of questions companies should be asking when considering or planning an EAP. Please complete the form to the right to download the resource.